Emotions are indicators of affective states and play a significant role in human daily life, behavior, and interactions. Giving emotional intelligence to the machines could, for instance, facilitate early detection and prediction of (mental) diseases and symptoms. Electroencephalography (EEG) -based emotion recognition is being widely applied because it measures electrical correlates directly from the brain rather than the indirect measurement of other physiological responses initiated by the brain. The recent development of non-invasive and portable EEG sensors makes it possible to use them in real-time applications. Therefore, this paper presents a real-time emotion classification pipeline, which trains different binary classifiers for the dimensions of Valence and Arousal from an incoming EEG data stream. After achieving a 23.9% (Arousal) and 25.8% (Valence) higher f1-score on the state-of-art AMIGOS dataset, this pipeline was applied to the dataset achieved by an emotion elicitation experimental framework developed within the scope of this thesis. Following two different protocols, 15 participants were recorded using two different consumer-grade EEG devices while watching 16 short emotional videos in a controlled environment. For an immediate label setting, the mean f1-score of 87% and 82% were achieved for Arousal and Valence, respectively. In a live scenario, while continuously being updated on the incoming data stream with delayed labels, the pipeline proved to be fast enough to achieve predictions in real time. However, the significant discrepancy from the readily available labels on the classification scores leads to future work to include more data with frequent delayed labels in the live settings.

Intermittent religious fasting increases a risk of hypo- and hyperglycemia in individuals with diabetes, but its impact in those without diabetes is poorly investigated. The study aim was to examine the effects of religious Bahá'í fasting (BF) on glycemic control and variability and compare these effects with time-restricted eating (TRE). In a three-arm randomized controlled trial, 16 subjects without diabetes were assigned to a BF, 16:8 TRE or control group. Continuous glucose monitoring and food intake documentation was conducted before and during the 19 days of intervention, and 24-hour mean glucose, glycemic variability indices, and glucotypes were assessed. BF and TRE groups, but not the control group, markedly reduced the daily eating window while maintaining macronutrient composition. Only the BF group decreased caloric intake (-677.8 ± 357.6 kcal, p=0.013), body weight (-1.92 ± 0.95 kg, p=0.011) and BMI (-0.65 ± 0.28 kg, p=0.006). Higher maximum glucose values were observed during BF in the within-group (+1.41 ± 1.04, p=0.039) and between-group comparison (BF vs. Control: p= 0.010 and TRE vs. BF: p= 0.022). However, there were no alterations of 24-hour mean glucose, intra- and inter-day glycemic variability indices, or glucotypes in any group. Proportions of time above and below range (70-180mg/dl) and HbA1c values remained unchanged. BF and TRE do not exhibit negative effects on glycemic control and variability in subjects without diabetes.